8 November 2018 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) has approved a new version of Primatene Mist (epinephrine) seven years after the OTC asthma inhaler was taken off the market.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.